Janssen

CARVYKTI - Cost

Last Updated: April 1st, 2024

HCPCS:

Q2056

HCPCS Code Descriptor:

Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Medicare Payment Limit:

The CARVYKTI Medicare Payment Limit is $507495.551

Average Sale Price:

CARVYKTI ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The CARVYKTI Medicare Co-insurance percentage is 20%. CARVYKTI's Medicare Co-insurance amount is $101499.11 per HCPCS unit.

APC Code:

The Carvykti APC Code is: 9498

APC Payment Limit:

The APC Payment Limit for CARVYKTI is available. Login to view.

Carvykti Cost Information:

CARVYKTI, became effective on October 1, 2022 and is aligned to HCPCS Q2056. Pricing has remained relatively level. AWP and WAC had a minimal increase, of a couple percentage points, early in 2023. They have remained at this level through 2024.

ACCESS PRICING AND MORE BY REGISTERING

Carvykti’s wholesale acquisition cost (WAC) information was last updated on:
March 31, 2023
Carvykti’s average wholesale price (AWP) information was last updated on:
March 31, 2023

Carvykti Cost Graph: